切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (02) : 3 -7. doi: 10.3877/cma.j.issn.1674-0807.2008.02.002

专家论坛

乳腺癌外科临床实践的点滴思考:区域淋巴结外科临床实践的方略
左文述1, 王磊1   
  1. 1.250117 济南,山东省肿瘤医院外科山东省乳腺病防治中心
  • 收稿日期:2008-01-16 出版日期:2008-04-01

Thinking of clinical practice of surgery for breast cancer:strategy of clinical practice of surgery of regional lymph nodes

Wen-shu ZUO, Lei WANG   

  • Received:2008-01-16 Published:2008-04-01
引用本文:

左文述, 王磊. 乳腺癌外科临床实践的点滴思考:区域淋巴结外科临床实践的方略[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(02): 3-7.

Wen-shu ZUO, Lei WANG. Thinking of clinical practice of surgery for breast cancer:strategy of clinical practice of surgery of regional lymph nodes[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(02): 3-7.

表1 乳腺癌生物学理论的变迁
表2 乳腺癌患者SLN 与腋窝淋巴结转移状态的比较
[1]
Fisher B, Redmond C,Fisher E R,et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med,1985,312:674 -681.
[2]
Boova R S, Bonanni R, Rosato F E. Patterns of axillary nodal involvement in breast cancer. predictability of level one dissection. Ann Surg,1982,196:642 -644.
[3]
Canavese G, Catturich A, Vecchio C, et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol,1998,24:104 -109.
[4]
Cody H S 3rd,Egeli R A,Urban J A.Rotter's node metastases.Therapeutic and prognostic considerations in early breast carcinoma. Ann Surg,1984,199:266 -270.
[5]
Rosen P P, Lesser M L, Kinne D W, et al. Discontinuous or“skip” metastases in breast carcinoma: analysis of 1228 axillary dissections. Ann Surg,1983,197:276 -283.
[6]
Spillane A J,Sacks N P. Role of axillary surgery in early breast cancer: review of the current evidence. Aust N Z J Surg,2000,70:515 -524.
[7]
Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion: an analysis of 539 cases.Cancer,1987,59:682 -687.
[8]
Harris J R, Osteen R T. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat,1985,5:17 -21.
[9]
Moffat F L Jr, Senofsky G M, Davis K, et al. Axillary node dissection for early breast cancer: some is good,but all is better. J Surg Oncol,1992,51:8 -13.
[10]
Schwartz G F, D' Ugo D M, Rosenberg A L. Extent of axillary dissection preceding irradiation for carcinoma of the breast.Arch Surg,1986,121:1395 -1398.
[11]
Degnim A C,Oh K,Cimmino V M,et al.Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Ann Surg Oncol,2005,12:712- 717.
[12]
Martin R C 2nd,Chagpar A,Scoggins C R,et al.Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.Ann Surg,2005,241:1005 -1012.
[13]
毕晔,边莉,黄椠,等. 乳腺癌热点问题研究的现状分析. 中华肿瘤防治杂志,2006,13:1205 -1211.
[14]
Fisher E R, Dignam J, Tan Chiu E, et al.Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP)eight-year update of Protocol B-17: intraductal carcinoma.Cancer,1999,86:429 -438.
[15]
Kargozaran H, Shah M, Li Y, et al. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. J Surg Res,2007,143:126 -129.
[16]
Anan K,Mitsuyama S, Kuga H, et al. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer:2-site injection is more accurate than 1-site injection. Surgery,2006,139:624 -629.
[17]
Rodier J F, Velten M, Wilt M, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.J Clin Oncol,2007,25:3664 -3669.
[18]
刘奇,左文述,王永胜,等.乳腺癌哨位淋巴结临床意义的研究.肿瘤防治杂志,2000,7:247 -253.
[19]
左文述,王永胜,李敏,等.乳腺癌哨位淋巴结活检的临床意义.中华肿瘤杂志,2001,23:247 -250.
[20]
王永胜,王磊,刘娟娟,等.临床早期乳腺癌前哨淋巴结活检替代腋清扫术的研究. 实用临床医药杂志,2003,7:99 -103.
[21]
Kim T, Giuliano A E, Lyman G H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis. Cancer,2006,106:4 -16.
[22]
Horino T, Fujita M, Ueda N, et al. Efficacy of internal mammary node dissection in the treatment of breast cancer. Jpn J Clin Oncol,1991,21:422 -427.
[23]
Noguchi M,Ohta N,Koyasaki N,et al. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer,1991,68:1918 -1925.
[24]
Konishi Y, Hashimoto T, Okuno T, et al. Preoperative diagnosis of internal mammary node metastases in patients with breast cancer by using ultrasonography. Nippon Geka Gakkai Zasshi,1992,93:1330 -1336.
[25]
Turoglu H T, Janjan N A, Thorsen M K, et al. Imaging of regional spread of breast cancer by internal mammary lymphoscintigraphy,CT,and MRI. Clin Nucl Med,1992,17:482 -484.
[26]
Noguchi M, Tsugawa K, Miwa K. Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol,2000,73:75 -80.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 潘荔生, 刘忠强, 周莹莹, 陈勃, 李晏宁, 徐金锋, 蔡隆梅, 王宏梅. 乳腺癌内乳淋巴结的诊断和治疗[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 308-314.
[5] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[6] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[7] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[8] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[9] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[10] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
阅读次数
全文


摘要